Christian Schwabe

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Top Venues

Clinical and translational science

Nature medicine

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, Winnie Weng, Kai-Wen Lin, Emon Elboudwarej, Ann Ran-Ran Qin, Christian Schwabe, Michelle R Kuhne, Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants. Clinical and translational science 17 (8) (2024)
Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, Winnie Weng, Kai-Wen Lin, Emon Elboudwarej, Ann Ran-Ran Qin, Christian Schwabe, Michelle R Kuhne, Ahmed A Othman
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants. Clinical and translational science 17 (8) (2024)
Gerald F Watts, Christian Schwabe, Russell Scott, Patrick A Gladding, David Sullivan, John Baker, Peter Clifton, James Hamilton, Bruce Given, Stacey Melquist, Rong Zhou, Ting Chang, Javier San Martin, Daniel Gaudet, Ira J Goldberg, Joshua W Knowles, Robert A Hegele, Christie M Ballantyne
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts. Nature medicine (2023)
Man Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen, Sang Hoon Ahn, Tawesak Tanwandee, Young Suk Lim, Yun Joon Kim, Kittiyod Poovorawan, Pisit Tangkijvanich, Christian Schwabe, Timothy Eley, Joanne Brown, Amy C H Lee, Emily P Thi, Bhavna Paratala, Nagraj Mani, Michael J Sofia, Gaston Picchio, Karen D Sims, Edward J Gane
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B. Hepatology communications 6 (12) (2022)